Shin, T.-H.; Ahn, J.-S.; Oh, S.-J.; Shin, Y.Y.; Yang, J.W.; Kang, M.-J.; Kim, J.M.; Lee, B.-J.; Seo, Y.; Kim, H.-S.
TNF-α Priming Elicits Robust Immunomodulatory Potential of Human Tonsil-Derived Mesenchymal Stem Cells to Alleviate Murine Colitis. Biomedicines 2020, 8, 561.
https://doi.org/10.3390/biomedicines8120561
AMA Style
Shin T-H, Ahn J-S, Oh S-J, Shin YY, Yang JW, Kang M-J, Kim JM, Lee B-J, Seo Y, Kim H-S.
TNF-α Priming Elicits Robust Immunomodulatory Potential of Human Tonsil-Derived Mesenchymal Stem Cells to Alleviate Murine Colitis. Biomedicines. 2020; 8(12):561.
https://doi.org/10.3390/biomedicines8120561
Chicago/Turabian Style
Shin, Tae-Hoon, Ji-Su Ahn, Su-Jeong Oh, Ye Young Shin, Ji Won Yang, Min-Jung Kang, Ji Min Kim, Byung-Joo Lee, Yoojin Seo, and Hyung-Sik Kim.
2020. "TNF-α Priming Elicits Robust Immunomodulatory Potential of Human Tonsil-Derived Mesenchymal Stem Cells to Alleviate Murine Colitis" Biomedicines 8, no. 12: 561.
https://doi.org/10.3390/biomedicines8120561
APA Style
Shin, T.-H., Ahn, J.-S., Oh, S.-J., Shin, Y. Y., Yang, J. W., Kang, M.-J., Kim, J. M., Lee, B.-J., Seo, Y., & Kim, H.-S.
(2020). TNF-α Priming Elicits Robust Immunomodulatory Potential of Human Tonsil-Derived Mesenchymal Stem Cells to Alleviate Murine Colitis. Biomedicines, 8(12), 561.
https://doi.org/10.3390/biomedicines8120561